Literature DB >> 18091373

Primary Sjögren syndrome complicated by autoimmune hemolytic anemia and pure red cell aplasia.

Stelios F Assimakopoulos1, Sotiria Michalopoulou, Maria Melachrinou, Nikolaos Giannakoulas, Christos Papakonstantinou, Alexandra Lekkou, Charalambos Gogos.   

Abstract

Patients with primary Sjögren syndrome frequently present hematologic abnormalities, consisting mainly of immune cytopenias. Pure red cell aplasia is a very rare complication of primary Sjögren syndrome. This is the first report in the literature describing the development of pure red cell aplasia combined with autoimmune hemolytic anemia in a 74-year-old woman with primary Sjögren syndrome. In our patient, despite administration of diverse therapeutic schemes, such as corticosteroids, immunomodulating agents (intravenous immune globulin), immunosuppressive drugs (cyclophosphamide), and novel treatment options (monoclonal antibody directed against the CD20 antigen), no response was achieved. The present case suggests that the possibility of comorbid connective tissue disease should be a diagnostic consideration in patients with acquired pure red cell aplasia and autoimmune hemolytic anemia. Although most of the hematologic abnormalities that occur in primary Sjögren syndrome are not clinically significant, serious and difficult-to-treat hematologic complications may also occur.

Entities:  

Mesh:

Year:  2007        PMID: 18091373     DOI: 10.1097/MAJ.0b013e318068b5fd

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  4 in total

1.  Clinical and serologic features of primary Sjögren's syndrome concomitant with autoimmune hemolytic anemia: a large-scale cross-sectional study.

Authors:  Wen Wen; Yanying Liu; Chuchu Zhao; Xiaolin Sun; Chunfang Zhang; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2015-10-01       Impact factor: 2.980

2.  Autoimmune haemolytic anaemia associated with mantle cell lymphoma.

Authors:  Heather E Eve; Simon A J Rule
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

3.  Pure red cell aplasia caused by ribavirin and interferon treatment.

Authors:  Andrew J Skabelund; Timothy R Hauser; Kevin J Goist
Journal:  Clin J Gastroenterol       Date:  2011-07-30

4.  Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin.

Authors:  Atsushi Isoda; Yuri Miyazawa; Kenichi Tahara; Masahiro Mihara; Akio Saito; Morio Matsumoto; Morio Sawamura
Journal:  Intern Med       Date:  2020-05-08       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.